Fluorescence Observables and Enzyme Kinetics in the Investigation of PPI Modulation by Small Molecules: Detection, Mechanistic Insight, and Functional Consequences

The potential of fluorescence-based methods and kinetic analysis in the screening and molecular-scale mechanistic investigation of PPI modulation by small molecules is discussed through several representative examples collected and commented. These experimental approaches take advantage of a variety of observables. Changes in the protein aggregation pattern have been monitored through fluorescence properties such as spectra, intensities (related to quantum yields), time-decays, and anisotropies of intrinsic protein fluorophores, of extrinsic fluorescent tags and, even, of the same small molecules added to modulate PPIs, as well as through bimolecular excited-state processes such as static and collisional quenching, including electron and excitation-energy transfer, or exciton interaction, whose efficiencies are crucially structure dependent. Besides allowing for qualitative and quantitative information on the small-molecule induced PPI modulation, these approaches can take advantage from the sensitivity of fluorescence observables on fine structural details to shed light on the molecular-scale mechanisms of action and their functional consequences. Direct investigation of the latter by kinetic inhibition analysis represents a useful change in perspective whenever PPI are relevant for enzyme activity. Dissociative inhibition, that is, the ability of some small molecules to inhibit enzymes by disrupting their active oligomeric assembly is shortly reviewed.

• Publication year

  2013

• Venue

  Disruption of Protein-Protein Interfaces

• Publication date

  2013-06-28

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1007/978-3-642-37999-4_6PMCID 7123529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction

  2012cited by this paper
• On the use of size exclusion chromatography for the resolution of mixed amyloid aggregate distributions: I. equilibrium partition models.

  2012cited by this paper
• Modulating protein-protein interactions with small molecules: the importance of binding hotspots.

  2012cited by this paper
• Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism.

  2011cited by this paper
• Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formation.

  2011cited by this paper
• Targeting Ovarian Tumor Cell Adhesion Mediated by Tissue Transglutaminase

  2011cited by this paper
• A homogeneous fluorescence resonance energy transfer system for monitoring the activation of a protein switch in real time.

  2011cited by this paper
• Fluorescent small molecule probe to modulate and explore α2β1 integrin function.

  2011cited by this paper
• Time-resolved FRET biosensor based on amine-functionalized lanthanide-doped NaYF4 nanocrystals.

  2011cited by this paper
• High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.

  2011cited by this paper
• Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor

  2011cited by this paper
• Organization of higher-order oligomers of the serotonin₁(A) receptor explored utilizing homo-FRET in live cells.

  2011cited by this paper
• Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied.

  2011cited by this paper
• Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase

  2011cited by this paper
• Measuring the effect of ligand binding on the interface stability of multimeric proteins using dynamic light scattering.

  2010cited by this paper
• A Time-Resolved Fluorescence–Resonance Energy Transfer Assay for Identifying Inhibitors of Hepatitis C Virus Core Dimerization

  2010cited by this paper
• Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins

  2010cited by this paper
• Homodimeric enzymes as drug targets.

  2010cited by this paper
• Dimer–monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer

  2010cited by this paper
• The association−dissociation behavior of the ApoE proteins: kinetic and equilibrium studies.

  2010cited by this paper
• A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.

  2010cited by this paper
• Ligand-induced EGF Receptor Oligomerization Is Kinase-dependent and Enhances Internalization*

  2010cited by this paper
• Toward the First Nonpeptidic Molecular Tong Inhibitor of Wild‐Type and Mutated HIV‐1 Protease Dimerization

  2010cited by this paper
• A Cy5-Labeled S100A10 Tracer Used to Identify Inhibitors of the Protein Interaction With Annexin A2

  2010cited by this paper
• Time-resolved FRET fluorescence spectroscopy of visible fluorescent protein pairs

  2009cited by this paper
• Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex

  2009cited by this paper
• Fluorescence lifetime and polarization-resolved imaging in cell biology.

  2009cited by this paper
• Fluorescent Biosensors of Intracellular Targets from Genetically Encoded Reporters to Modular Polypeptide Probes

  2009cited by this paper
• Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.

  2009cited by this paper
• Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands.

  2009cited by this paper
• Homo-FRET imaging enables quantification of protein cluster sizes with subcellular resolution.

  2009cited by this paper
• Sidechain-linked inhibitors of HIV-1 protease dimerization.

  2009cited by this paper
• Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum.

  2009cited by this paper
• Protein-protein interactions determined by fluorescence correlation spectroscopy.

  2008cited by this paper
• Protein aggregation probed by two-photon fluorescence correlation spectroscopy of native tryptophan.

  2008cited by this paper
• Strategies to search and design stabilizers of protein–protein interactions: A feasibility study

  2007cited by this paper
• Deciphering Protein–Protein Interactions. Part I. Experimental Techniques and Databases

  2007cited by this paper
• Aggregation Analysis of Therapeutic Proteins , Part 1 General Aspects and Techniques for Assessment

  2006cited by this paper
• Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization.

  2006cited by this paper
• Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.

  2006cited by this paper
• Rapid synthesis and in situ screening of potent HIV-1 protease dimerization inhibitors.

  2006cited by this paper
• Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?

  2006cited by this paper
• Weak protein-protein interactions as probed by NMR spectroscopy.

  2006influential reference
• The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase

  2005cited by this paper
• New methodologies for measuring protein interactions in vivo and in vitro.

  2005cited by this paper
• Development of low molecular weight HIV-1 protease dimerization inhibitors.

  2005cited by this paper
• Targeting protein–protein interactions for cancer therapy

  2005cited by this paper
• A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction.

  2005cited by this paper
• Surface plasmon resonance

  2005cited by this paper
• Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.

  2005cited by this paper
• Discovery of AICAR Tfase inhibitors that disrupt requisite enzyme dimerization.

  2005cited by this paper
• Small-Molecule Inhibition of TNF-α

  2005cited by this paper
• Consequences of H-dimerization on the photophysics and photochemistry of oxacarbocyanines

  2004cited by this paper
• SPR for molecular interaction analysis: a review of emerging application areas

  2004cited by this paper
• Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

  2004cited by this paper
• Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

  2004cited by this paper
• Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.

  2004cited by this paper
• New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer.

  2004cited by this paper
• Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions.

  2004cited by this paper
• Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface.

  2004cited by this paper
• Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.

  2004cited by this paper
• Progress in Lanthanides as Luminescent Probes

  2004cited by this paper
• Correlating Protein Structure and Protein Fluorescence

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Structure-based design of potent, conformationally constrained Smac mimetics.

  2004cited by this paper
• α-Synuclein structures from fluorescence energy-transfer kinetics: Implications for the role of the protein in Parkinson's disease

  2004cited by this paper
• Discovery of a potent small molecule IL-2 inhibitor through fragment assembly.

  2003cited by this paper
• Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins.

  2003cited by this paper
• Identification of Chelerythrine as an Inhibitor of BclXL Function*

  2003cited by this paper
• Modulation of protein-protein interactions with small organic molecules.

  2003cited by this paper
• Subunit interface mutation disrupting an aromatic cluster in Plasmodium falciparum triosephosphate isomerase: effect on dimer stability.

  2002cited by this paper
• Mapping protein-protein interactions in solution by NMR spectroscopy.

  2002cited by this paper
• Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners.

  2002cited by this paper
• Protein–protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two‐fusion fluorescence resonance energy transfer (FRET)

  2001cited by this paper
• Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

  2001cited by this paper
• Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.

  2001cited by this paper
• The analysis of time resolved protein fluorescence in multi-tryptophan proteins.

  2001cited by this paper
• Molecular Fluorescence: Principles and Applications

  2001influential reference
• Photophysical Properties of Fluorescent DNA-dyes Bound to Single- and Double-stranded DNA in Aqueous Buffered Solution¶

  2001cited by this paper
• The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo.

  2001cited by this paper
• Discovery of potent antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 3. Amide (C-ring) structure-activity relationship and improvement of overall properties of arylthio cinnamides.

  2001cited by this paper
• Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A.

  2001cited by this paper
• Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3

  2001influential reference
• Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells.

  2000cited by this paper
• Genetic selection for dissociative inhibitors of designated protein–protein interactions

  2000cited by this paper
• Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

  2000cited by this paper
• Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead.

  2000cited by this paper
• Measuring protein-protein interactions.

  1998cited by this paper
• Switching signals on or off by receptor dimerization.

  1998cited by this paper
• Synthetic interface peptides as inactivators of multimeric enzymes: inhibitory and conformational properties of three fragments from Lactobacillus casei thymidylate synthase.

  1998cited by this paper
• TARGETING THE DIMERIZATION INTERFACE OF HIV-1 PROTEASE: INHIBITION WITH CROSS-LINKED INTERFACIAL PEPTIDES

  1997cited by this paper
• Principles and Applications

  1997cited by this paper
• Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis

  1997cited by this paper
• Role of ligand in retinoid signaling. 9-cis-retinoic acid modulates the oligomeric state of the retinoid X receptor.

  1995cited by this paper
• Protein-protein interactions: methods for detection and analysis

  1995cited by this paper
• Interaction between the retinal cyclic GMP phosphodiesterase inhibitor and transducin. Kinetics and affinity studies.

  1993cited by this paper
• The application of size exclusion chromatography and computer simulation to study the thermodynamic and kinetic parameters for short-lived dissociable protein aggregates.

  1993cited by this paper
• Receptor-ligand interactions : a practical approach

  1992cited by this paper
• Synthetic “interface” peptides alter dimeric assembly of the HIV 1 and 2 proteases

  1992cited by this paper
• Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide.

  1991cited by this paper

• No citing papers are available for this paper.